more_reports

Enanta Pharmaceuticals Inc.

ENTA:NASDAQ

Enanta's research and development efforts are currently focused on the following disease targets: respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH)/ primary biliary cholangitis (PBC), and hepatitis B virus (HBV).

streetwise book logo Streetwise Company Fact Sheet

2024/12/23 15:32:54

(ENTA:NASDAQ)